Skip to main content

Jeffrey F. Eisenberg

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jeffrey F. Eisenberg

Earlier roles on record: CEO and Board Member at Xenetic Biosciences, Inc. (XBIO) until May 16, 2024. Xenetic Biosciences, Inc. reported in an 8-K filed May 22, 2024 that Jeffrey F. Eisenberg resigned as director, effective May 16, 2024. The proxy statement of Xenetic Biosciences, Inc. reports total compensation of $673,143 for Jeffrey F. Eisenberg in fiscal 2024, including a base salary of $201,843. Disclosed compensation is on record for 7 fiscal years.

“On May 16, 2024, the Company and Jeffrey F. Eisenberg mutually agreed that Mr. Eisenberg would step down as the Chief Executive Officer of the Company, effective immediately, and in connection therewith, Mr. Eisenberg resigned as a director of the Company and all of its subsidiaries, as applicable.”
Xenetic Biosciences, Inc. Form 8-K, filed May 22, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Xenetic Biosciences, Inc. (XBIO) $201,843 $673,143
2023 Xenetic Biosciences, Inc. (XBIO) $404,250 $563,494
2022 Xenetic Biosciences, Inc. (XBIO) $404,250 $632,827
2021 Xenetic Biosciences, Inc. (XBIO) $367,500 $750,231
2020 Xenetic Biosciences, Inc. (XBIO) $350,000 $446,357
2019 Xenetic Biosciences, Inc. (XBIO) $300,000 $602,652
2018 Xenetic Biosciences, Inc. (XBIO) $300,000 $318,333

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.